¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Á¦27Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2022-09-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Á¦27Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2022-09-02
±³À°ÀÏÀÚ : 2022-09-02
±³À°Àå¼Ò : ÀÌ´ë¼­¿ïº´¿ø ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç  
±³À°ÁÖÁ¦ : 2022³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Á¦27Â÷ Çмú´ëȸ (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ
´ã´çÀÚ : ±èÀºÁÖ
¿¬¶ôó : 02-704-8574  
À̸ÞÀÏ : app@app2010.com      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 110,000¿ø      
ºñ°í Àü¹®ÀÇ(ȸ¿ø-¿¬È¸ºñ³³ºÎÀÚ) »çÀüµî·Ï50,000/ÇöÀåµî·Ï60,000 * Àü¹®ÀÇ(ȸ¿ø-¿¬È¸ºñ¹Ì³³ÀÚ) »çÀüµî·Ï100,000/ÇöÀåµî·Ï110,000* Àü¹®ÀÇ(ºñȸ¿ø) »çÀüµî·Ï100,000/ÇöÀåµî·Ï110,000 * °£È£»ç(ȸ¿ø-¿¬È¸ºñ³³ºÎÀÚ) »çÀüµî·Ï30,000/ÇöÀåµî·Ï40,000 * °£È£»ç(ȸ¿ø-¿¬È¸ºñ¹Ì³³ÀÚ) »çÀüµî·Ï80,000/ÇöÀåµî·Ï90,000 * °£È£»ç(ºñȸ¿ø) »çÀüµî·Ï80,000/ÇöÀåµî·Ï90,000 * ±ºÀÇ°ü,°øº¸ÀÇ,Àü°øÀÇ,ÀÇ°ú,°£È£´ëÇлý / »çÀüµî·Ï ¹«·á , ÇöÀåµî·Ï 40,000* 65¼¼ ÀÌ»ó ȸ¿ø / »çÀüµî·Ï ¹«·á. ÇöÀåµî·Ï ¹«·á(»çÀüµî·Ï¿¡ ÇÑÇÔ)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 08:30~09:00 Registration  () 
±âŸ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 09:00~09:05 Opening Remarks  () 
±âŸ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 09:05~09:10 Congratulatory Remarks  () 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 09:10~09:30 Pros  ½ÅÁ¤Çö(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 09:30~09:50 Cons  °í±¤Áø(¼º±Õ°üÀÇ´ë) 
Åä·Ð 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 09:50~10:10 Panel discussion  () 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 10:10~10:40 Minimal invasive treatment of small BPH: Is HOLEP still the gold standard  ±è¸í±â(ÀüºÏÀÇ´ë) 
È޽Ġ09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 10:40~11:00 Coffee Break  () 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 11:00~11:15 Refractory nocturia: poor efficacy or side effect of desmopressin  Á¶¿µ»ï(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 11:15~11:30 Recurrent simple UTI  ÃÖÈÆ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 11:30~11:45 Recurrent gross hematuria after pelvic radiation therapy  ½Åµ¿±æ(ºÎ»êÀÇ´ë) 
Åä·Ð 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 11:45~12:05 Panel discussion  () 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 12:05~13:00 Current status of the combination pills for LUTS  Ã߹μö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 13:00~13:20 Mechanisms of stress affecting lower urinary tract symptoms  À±Çϳª(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 13:20~13:40 Immune-related diseases and lower urinary tract symptoms  ±ÇÁعü(´ë±¸ÆÄƼ¸¶º´¿ø) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 13:40~14:00 Diverse pathophysiologies focused on OAB  ½ÅÁÖÇö(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 14:00~14:30 Persistent BOO and bladder dysfunction  ±è¼öÁø(ÇѸ²ÀÇ´ë) 
±âŸ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 14:30~14:45 Desmopressin Áø·áÁöħ ¹ßÇ¥  ¿©Á¤±Õ(ÀÎÁ¦ÀÇ´ë) 
È޽Ġ09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 14:45~15:05 Coffee Break  () 
±âŸ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 15:05~15:20 Report from The Committees: Public Relations Committee  ¹èÀçÇö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 15:20~15:50 Pathophysiology & novel pharmacological targets for underactive bladder  ±è¾Æ¶÷(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 15:50~16:10 Issue 1: Patients with CP/CPPS  Á¶Àη¡(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 16:10~16:30 Issue 2: Patients with IC/BPS  ±è¿µÈ£(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 16:30~16:50 Issue 3: Patients with neurogenic bladder  ¿À½ÂÁØ(¼­¿ïÀÇ´ë) 
Åä·Ð 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 16:50~17:20 Panel discussion  () 
±âŸ 09-02 ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç 17:20~17:30 Closing Remarks & Group photo  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Á¦27Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2022-09-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦ 58Â÷ ´ëÇѼö¸éÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2022-09-02
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ¾È°ú ±Ý¿äÁý´ãȸ(¾ß¸¶³× °ø¸·°íÁ¤¼ú) : 2022-09-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 1 15:07:03
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 1 15:04:54
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 1 15:03:12
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 1 15:01:06
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 0 14:59:21
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 0 14:57:48
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 0 14:56:11
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 0 14:53:49
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 0 14:52:21
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 0 14:50:56
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 0 14:49:27
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 0 14:48:12
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 0 14:46:55
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 1 14:45:22
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 1 14:43:02
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷